Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Aetna Inc    AET

Delayed Quote. Delayed  - 07/29 03:53:08 pm
115.43 USD   -0.31%
02:10p When Big Insurance Companies Merge, Who Benefits?
01:36pDJCigna Misses, Cuts Guidance
12:14p AETNA : Earnings schedule for the week of 8/1/2016
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Goldman M&A head Sykes joins management committee

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/19/2012 | 11:07pm CEST

Gene Sykes, global head of Goldman Sachs Group Inc's (>> Goldman Sachs Group, Inc.) mergers and acquisitions business, has been named to the investment bank's management committee, according to an internal memo.

Gene Sykes, global head of Goldman Sachs Group Inc's (>> Goldman Sachs Group, Inc.) mergers and acquisitions business, has been named to the investment bank's management committee, according to an internal memo.

The 54-year-old investment banker joins 28 other executives on the powerful committee, which includes Chief Executive Lloyd Blankfein and Chief Operating Officer Gary Cohn, and influences decisions about Goldman's business strategy and operations.

Sykes' appointment comes just nine days after the departure of another prominent Goldman banker, Yoel Zaoui, was announced in a separate internal memo. Zaoui shared the title of M&A co-head with Sykes and had also been on the management committee.

Sykes, who is based in Los Angeles, is also chairman of the global technology, media and telecommunications department of the investment banking division. He is a member of Goldman's internal Business Standards Committee.

The Goldman veteran joined the firm in 1984 and became a partner in 1992. He has advised on several high-profile deals, including Walt Disney Co's (>> The Walt Disney Company) acquisition of Pixar, Aetna Inc's (>> Aetna Inc.) acquisition of U.S. Healthcare and Roche Holding AG acquisition of Genentech.

"Gene has played a vital role in strengthening our investment banking franchise, particularly with respect to many of the most significant companies in technology and media," Blankfein and Cohn said in the memo, whose contents were confirmed by a spokesman.

(Reporting By Lauren Tara LaCapra in New York; editing by Andre Grenon)

By Lauren Tara LaCapra

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AETNA INC
02:10p When Big Insurance Companies Merge, Who Benefits?
01:36pDJCigna Misses, Cuts Guidance
12:14p AETNA : Earnings schedule for the week of 8/1/2016
07/28AETNA INC : half-yearly earnings release
07/27 AETNA : Boys Arnold & Co INC Decreased Stake in Aetna INC New by $6.85 Million a..
07/26 AETNA : Georgia officials postpone Aetna-Humana merger hearing
07/25DJCanceled Deals Put M&A Record at Risk -- WSJ
07/25 AETNA : NOAA deploys another smart buoy in the bay
07/24 AETNA : Cigna Futures Foggy In Wake Of Justice Department Decisions To Block Dea..
07/22 AETNA INC /PA/ : Other Events, Financial Statements and Exhibits (form 8-K)
More news
Sector news : Managed Healthcare - NEC
01:36pDJCigna Misses, Cuts Guidance
01:22pDJCIGNA : Misses, Cuts Guidance
07/28DJANTHEM : Turns Less Bullish On Exchanges -- WSJ
07/27DJAlere Faces Criminal Probe Over Medicare, Medicaid Billing
07/27DJANTHEM : Projecting Losses on Affordable Care Act Plans This Year
More sector news : Managed Healthcare - NEC
News from SeekingAlpha
07/21 U.S. Gov sues to block two health insurance mega-mergers
07/21 WALL STREET BREAKFAST : ECB Holds First Meeting Since Brexit
07/21 Aetna, Humana still talking to DOJ
07/20 United Health Today, Centene And Humana Tomorrow
07/19 U.S. to oppose Cigna/Humana deals
Advertisement
Financials ($)
Sales 2016 63 076 M
EBIT 2016 4 540 M
Net income 2016 2 638 M
Debt 2016 4 521 M
Yield 2016 0,86%
P/E ratio 2016 15,56
P/E ratio 2017 13,95
EV / Sales 2016 0,72x
EV / Sales 2017 0,66x
Capitalization 40 596 M
More Financials
Chart AETNA INC
Duration : Period :
Aetna Inc Technical Analysis Chart | AET | US00817Y1082 | 4-Traders
Full-screen chart
Technical analysis trends AETNA INC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 138 $
Spread / Average Target 19%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Mark T. Bertolini Chairman & Chief Executive Officer
Karen S. Lynch President
Margaret M. McCarthy Executive Vice President-Operations & Technology
Shawn M. Guertin CFO, Executive VP & Chief Enterprise Risk Officer
Harold L. Paz Chief Medical Officer & Executive Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
AETNA INC7.09%40 596
UNITEDHEALTH GROUP INC21.35%135 737
ANTHEM INC-4.69%34 975
CIGNA CORPORATION-7.07%34 883
HUMANA INC-3.53%25 666
CENTENE CORP6.31%11 945
More Results